Bo Han

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Venues

The Prostate

Medical oncology (Northwood, London, England)

Cellular and molecular life sciences : CMLS

Oncogene

This page only lists publications with an associated author ORCID identifier.

Publications

Tingting Feng, Ru Zhao, Hanwen Zhang, Feifei Sun, Jing Hu, Meng Wang, Mei Qi, Ling Liu, Lin Gao, Yabo Xiao, Junhui Zhen, Weiwen Chen, Lin Wang, Bo Han
Reciprocal negative feedback regulation of ATF6α and PTEN promotes prostate cancer progression. Cellular and molecular life sciences : CMLS 80 (10) (2023)
Feifei Sun, Xinpei Wang, Jing Hu, Junmei Liu, Xin Wang, Wenqiao Jia, Zeyuan Yu, Lin Gao, Baokai Dou, Ru Zhao, Tingting Feng, Xueli Wang, Wenbo Zhang, Hui Liu, Kaihua Liu, Yang Shao, Xuesen Dong, Bo Han
RUVBL1 promotes enzalutamide resistance of prostate tumors through the PLXNA1-CRAF-MAPK pathway. Oncogene 41 (23) (2022)
Ru Zhao, Ye Lv, Tingting Feng, Ruojia Zhang, Luna Ge, Jihong Pan, Bo Han, Guanhua Song, Lin Wang
ATF6α promotes prostate cancer progression by enhancing PLA2G4A-mediated arachidonic acid metabolism and protecting tumor cells against ferroptosis. The Prostate 82 (5) (2022)
Xinjun Li, Meng Jiao, Jing Hu, Mei Qi, Jing Zhang, Mingfeng Zhao, Hui Liu, Xueting Xiong, Xuesen Dong, Bo Han
miR-30a inhibits androgen-independent growth of prostate cancer via targeting MYBL2, FOXD1, and SOX4. The Prostate 80 (9) (2020)
Xueli Wang, Mei Qi, Jing Zhang, Xiubin Sun, Hongwei Guo, Yu Pang, Qian Zhang, Xinyi Chen, Ruifeng Zhang, Zhiyan Liu, Long Liu, Xiaomeng Hao, Bo Han
Differential response to neoadjuvant hormonal therapy in prostate cancer: Predictive morphological parameters and molecular markers. The Prostate 79 (7) (2019)
Mingfeng Zhao, Mei Qi, Xinjun Li, Jing Hu, Jing Zhang, Meng Jiao, Xinnuo Bai, Xijia Peng, Bo Han
CUL4B/miR-33b/C-MYC axis promotes prostate cancer progression. The Prostate 79 (5) (2019)
Meng Jiao, Mei Qi, Facai Zhang, Jing Hu, Tingting Feng, Mingfeng Zhao, Xinjun Li, Hui Liu, Wei Teng, Jing Zhang, Zhiyan Liu, Lili Zhang, Zhen Wu, Bo Han
CUL4B regulates cancer stem-like traits of prostate cancer cells by targeting BMI1 via miR200b/c. The Prostate 79 (11) (2019)
Hongyan Dong, Jing Hu, Lin Wang, Mei Qi, Ning Lu, Xiao Tan, Muyi Yang, Xinnuo Bai, Xuemei Zhan, Bo Han
SOX4 is activated by C-MYC in prostate cancer. Medical oncology (Northwood, London, England) 36 (11) (2019)

Bo Han.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Bo Han